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Abstract
Background: The use of obstetric early-warning-systems (EWS) has been recommended to improve timely recognition,
management and early referral of women who have or are developing a critical illness. Development of such prediction
models should involve a statistical combination of predictor clinical observations into a multivariable model which should be
validated. No obstetric EWS has been developed and validated for low resource settings. We report on the development
and validation of a simple prediction model for obstetric morbidity and mortality in resource-limited settings.
Methods:We performed a multivariate logistic regression analysis using a retrospective case-control analysis of secondary
data with clinical indices predictive of severe maternal outcome (SMO). Cases for design and validation were randomly
selected (n= 500) from 4360 women diagnosed with SMO in 42 Nigerian tertiary-hospitals between June 2012 and mid-
August 2013. Controls were 1000 obstetric admissions without SMO diagnosis. We used clinical observations collected within
24 h of SMO occurrence for cases, and normal births for controls. We created a combined dataset with two controls per
case, split randomly into development (n= 600) and validation (n= 900) datasets. We assessed the model’s validity using
sensitivity and specificity measures and its overall performance in predicting SMO using receiver operator characteristic (ROC)
curves. We then fitted the final developmental model on the validation dataset and assessed its performance. Using the
reference range proposed in the United Kingdom Confidential-Enquiry-into-Maternal-and-Child-Health 2007-report, we
converted the model into a simple score-based obstetric EWS algorithm.
Results: The final developmental model comprised abnormal systolic blood pressure-(SBP > 140mmHg or < 90mmHg),
high diastolic blood pressure-(DBP > 90mmHg), respiratory rate-(RR > 40/min), temperature-(> 38 °C), pulse rate-(PR > 120/
min), caesarean-birth, and the number of previous caesarean-births. The model was 86% (95% CI 81–90) sensitive and 92%-
(95% CI 89–94) specific in predicting SMO with area under ROC of 92% (95% CI 90–95%). All parameters were significant in
the validation model except DBP. The model maintained good discriminatory power in the validation (n= 900) dataset (AUC
92, 95% CI 88–94%) and had good screening characteristics. Low urine output (300mls/24 h) and conscious level (prolonged
unconsciousness-GCS < 8/15) were strong predictors of SMO in the univariate analysis.
Conclusion:We developed and validated statistical models that performed well in predicting SMO using data from a low
resource settings. Based on these, we proposed a simple score based obstetric EWS algorithm with RR, temperature, systolic
BP, pulse rate, consciousness level, urinary output and mode of birth that has a potential for clinical use in low-resource
settings..
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Background
The World Health Organization (WHO) estimated that
303,000 maternal deaths occurred globally at the end of
the Millennium Development Goals (MDGs) in 2015.
Over 99% of these deaths occurred in low and middle-
income countries (LMICs), most of which made insuffi-
cient progress towards achieving the MDG maternal
health targets [1]. It is also estimated that there are 27
million episodes of direct obstetric complications annu-
ally which contribute to long-term pregnancy and child-
birth complications [2]. Following increasing access to
facility-based births, partly because of Universal Health
Coverage policies under the Sustainable Development
Goals since 2016, opportunities to ensure good quality
facility care are critical, if the new ambitious global and
national Maternal Mortality Ratio (MMR) targets are to
be achieved [3].
The increased burden of adverse outcomes, especially
in LMICs is believed to be due primarily to delays in the
recognition of pregnancy complications [4, 5]. Early
warning systems (EWSs) are clinical diagnostic predic-
tion models that involve serial clinical observations
(“track”) with criteria (“trigger”) to identify patients at
risk of complications [6]. A 2018 systematic review of
EWS used in obstetrics found that they are effective in
predicting adverse obstetric outcomes and reducing ob-
stetric morbidity [7]. The United Kingdom Confidential
Enquiry into Maternal and Child Health (CEMACH)
(2003–2005 report) recommended “the use of obstetric
EWS to improve timely recognition, treatment and refer-
ral of women who have or are developing a critical ill-
ness” [8]. Most of the available obstetric EWS versions
used subsequently were designed based on clinical con-
sensus rather than the application of recommended pre-
diction model development methodology that should
include statistical analysis of outcome measures [9–17].
Model development involves a statistical combination
of predictor clinical observations into a multivariable
model. The Transparent Reporting of a multivariable
prediction model for Individual Prognosis Or Diagnosis
(TRIPOD) statement recommends that new prediction
models are tested on data used in its development (in-
ternal validation) and data from a different population
(external validation) [10].
In 2013, the first statistically derived, obstetric EWS
was developed in the UK. It was internally validated
using clinical observations (physiological variables) col-
lected from 4400 women during their first 24 h of crit-
ical care admission [18]. The EWS developed showed a
good predictive ability to discriminate survivors from
non-survivors in the derivation dataset, as well as on an
external dataset [19]. However, since the database used
in the development, internal [18] and external validation
[19] of the EWS were only for women admitted to
critical care, the EWS may not be suitable for obstetric
populations without obvious need for critical care and in
a non-UK setting.
No obstetric EWS has been developed and validated
for a low resource setting. However, 14 of the 16 obstet-
ric EWS identified in a recent systematic review, had five
clinical observations of physiologic variables (pulse rate,
systolic and diastolic blood pressure, respiratory rate,
temperature and consciousness level) that can be easily
collected even in low resource settings [7].
We report on the development and validation of a
simple obstetric prediction model and EWS algorithm
for use in resource-limited settings.
Methods
Study design
The study was a retrospective case-control analysis of sec-
ondary data on admissions to inpatient obstetric wards in
Nigerian tertiary hospitals. Cases based on standardised
definitions were derived from the Nigerian near-miss
study, the largest prospective investigation of maternal
deaths and near-misses in Africa [20].. Controls were
women who were admitted for obstetric care at the same
time as the cases.
Study population and data sources
The study protocol and findings of the Nigerian Near-
miss study have been published elsewhere [20, 21]. All
women admitted to 42 Nigerian tertiary hospitals for
birth or within 42 days of birth or termination of preg-
nancy between June 2012 and August 2013 were eligible
for enrolment into the near-miss study. The study re-
ported severe maternal outcome (SMO) cases based on
the WHO near-miss criteria (organ dysfunction, clinical
and management-based) [20, 22].
For this analysis, we obtained data on 4360 women
who had SMO during the 14-month surveillance, includ-
ing 998 who died and 3362 who had a near-miss [22].
Overall, 2401 SMO cases occurred in 11 tertiary care
hospitals across the 3 northern sub-regions of Nigeria.
Cases (n = 500) were randomly selected from these, and
split into the design (n = 200) and validation (n = 300)
SMO cases dataset (Fig. 1). Three of the 11 tertiary care
hospitals were coveniently selected across the three sub-
regions (one tertiary hospital in each northern sub-
region) for control data collection. One thousand
women who were admitted for birth, between June 2012
and August 2013, when the near-miss study was con-
ducted and discharged with no SMO were recruited as
the controls.
The sample size estimate was based on a baseline
SMO prevalence of 4·8% from the near-miss case data-
set. At 5% level of significance, the analysis could detect
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an absolute difference in SMO prevalence of 6 and 5% at
90 and 80% powers, respectively.
All data were collected within 24 h of the occurrence
of SMO (for cases) (Oladapo et al., 2013) or 24 h of birth
or end of pregnancy (collected retrospectively for con-
trols). Figure 1 illustrates allocation into, and compos-
ition of, the development and validation data sets.
Data abstraction
Individual-level data on all study variables were ab-
stracted from the Near-miss study dataset (n = 4360) and
from the case notes of 1000 controls. These included
demographic characteristics (age, weight, height), obstet-
ric variables (parity, the number of antenatal clinic visits,
gestational age at the time of admission or birth, mode
of birth, interval from last pregnancy, the number of
previous caesarean section), diagnosis, length of stay in
hospital, and the last haematocrit measured before oc-
currence of outcome. Abnormal clinical indices were ex-
tracted from the cases dataset based on their definitions
codebook including high (> 140 mmHg) and low (< 90
mmHg) systolic blood pressure, high (> 90 mmHg) and
low (< 60 mmHg) diastolic blood pressure, high (> 38 °C)
and low (< 35 °C) temperature, marked tachycardia (PR >
120/min) and bradycardia (PR < 60/min), hypoxaemia
(SpO2 < 90%), severe tachypnoea (RR > 40/min) and bra-
dypnea (RR < 6/min), severe oliguria (urinary output<
300 mL in 24 h), and coma (Glasgow Coma Score < 8/
15). Among controls, data were collected as continuous
variables and classified based on the cut-off values in the
cases dataset codebook.
Outcome
The outcome measure for this analysis was SMO, com-
puted as the sum of maternal deaths and near-misses
and transformed into a binary variable: occurred or not.
Maternal death was defined according to the Inter-
national Classification of Diseases (ICD-10) [23].
Women were identified as maternal near-miss if they
met any of the three near-miss criteria (clinical criteria
related to specific disease entities, intervention-based
criteria and organ dysfunction-based criteria) [22].
Statistical methods
Characteristics of the study population were summarised
by means and standard deviations for continuous and
percentages for categorical variables. Continuous vari-
ables were compared between cases and controls with
independent sample t-tests or Mann Whitney U tests,
depending on whether or not variables were normally
distributed. Normality was assessed visually through dis-
tribution plots and with the Shapiro-Wilk test. Data for
1500 (cases = 500 and controls, n = 1000) study partici-
pants were randomly allocated into the development
dataset (n = 600) or validation data set (n = 900) with
two controls per case.
Fig. 1 Creation of the development and validation data sets
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Model building
Univariable logistic regression models were fitted to as-
sess the association between each predictor variable and
outcome (SMO). A stricter inclusion criterion was ap-
plied and therefore variables were only selected from the
univariable models for inclusion into the multivariable
model if the model had a p-value< 0·05. This yielded 22
potential variables for inclusion.
Multivariable logistic regression models were fitted
using a backward stepwise approach and factors were re-
moved from the model, one at a time based on the high-
est p-value> 0·05 and their likelihood ratio. When the
final model was achieved, a sensitivity test was per-
formed by including each of the eliminated variables, in
turn, into the final model to assess their significance.
None of these was found significant in the final model.
Variables were tested for collinearity, by a simple check
of the correlation coefficients, and were dropped to im-
prove parsimony of the model.
Model performance
Performance of the obstetric EWS clinical prediction
model from the development data set was tested on the
validation data set [24]. First, overall validity (sensitivity,
specificity, negative predictive value-NPV and positive
predictive value-PPV), as well as area under the curve
(AUC) for Receiver Operating Characteristics (ROC)
curves were assessed for the final model. Discrimination
was assessed using the c statistic or AUC, an estimate of
the probability of assigning higher risk to those who suf-
fered SMO compared to those who did not. The final
model was then applied to the validation dataset, and
performance was similarly assessed. Finally, we estimated
validity of the selected EWS predictors by applying the
final (developmental) model to the entire (n = 5243 after
excluding 117 missing data) dataset of cases and con-
trols, bearing in mind that the ratio of cases to controls
had been reversed – over 4 cases per control. All statis-
tical analyses were performed using Statistical Package
for the Social Sciences (SPSS) software version 25 and
Stata version 15·1. We constructed 95% confidence in-
tervals (CI) for all performance characteristics.
Obstetric EWS algorithm
Our statistically derived diagnostic prediction model
was modified based on the clinical importance of
rejected variables. Given that the cases data set pro-
vided categorised (binary) clinical variables, it was not
feasible to validate reference ranges for the different
model parameters. Hence, the final (validation) model
was converted into simple score-based obstetric EWS
algorithm using the reference range proposed in the
MEOWS chart recommended in the 2007 CEMACH
report [8] (Additional file 1).
Patient and public involvement statement
Patients were not involved in the development of the re-
search question or design of this study. Secondary pa-
tient monitoring data was used for this analysis.
Implications of this study will be disseminated through
patient groups and blogs in the study setting.
We present our findings according to the Transparent
Reporting of a multivariable prediction model for Indi-
vidual Prognosis Or Diagnosis statement [10].
Results
From the 97, 634 women admitted for pregnancy, child-
birth or puerperal complications during the 14months
of the Nigerian near-miss study, 4360 developed SMO
and their data were included in the cases data set. Of
these, 998 women died and 3362 suffered maternal near-
miss. A total of 117 (2·7%) women with SMO had miss-
ing data, with no records of the type of SMO they expe-
rienced. These women were excluded from the analyses
as the missingness was assumed to be at random. Lack
of data on other characteristics of these participants did
not allow for assessment of bias in dropping them from
the analysis. None of the control participants had miss-
ing parameters.
Characteristics of SMO cases and controls are given in
Table 1. Those who experienced SMO tended to be
older and more likely to be obese. They also stayed lon-
ger in hospital, with the mean number of days of admis-
sion four times greater than controls and were more
likely to be anaemic. There was no significant difference
in terms of parity, but SMO cases had more preterm
births and had more antenatal visits than the controls
(Table 1).
Overall, women who had abnormal clinical observa-
tion measurements (either lower or higher than normal),
based on the pre-defined cut-off points deciphered from
the cases dataset, were more likely to develop SMO than
controls (Table 2). Initially, bivariate analysis was per-
formed considering all 22 potential variables for entry in
the model. Of these, a total of 15 had significant p-values
< 0·05 (Table 2) and so these were considered for poten-
tial inclusion in the multiple regression model.
The significant variables were entered into a multiple lo-
gistic regression model. Both backward and forward step-
wise selection methods were used to build the final
parsimonious model, with the standard 5% significance
level for entry and removal. Both techniques produced the
same final (developmental) model, in five steps, with 8 pa-
rameters (high systolic blood pressure (> 140mmHg), low
systolic blood pressure (< 90mmHg), high diastolic blood
pressure (> 90mmHg), severe tachypn0ea (RR > 40/min),
fever (temperature > 38o C), marked tachycardia (PR >
120/min), mode of birth (caesarean or vaginal birth), and
the number of previous caesarean births).
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Risk of severe maternal outcome
Table 3 gives odds ratios of developing SMO for the var-
iables in the SMO models. From the developmental
model, risk of developing SMO was five times greater
among women with high systolic blood pressure (> 140
mmHg) and tachycardia (PR > 120/min), while low sys-
tolic BP (< 90 mmHg) increased SMO risk four times.
Caesarean birth during index admission was found to in-
crease risk of SMO significantly (odds ratio 6; 95% CI
2.8–12.5), but the number of previous caesarean sections
did not increase risk. Most importantly, the variables
with the highest risk of SMO in the developmental
model were fever (OR 116.5; 95% CI 13.0–147.4) and
tachypnoea, (OR 25.2; 95% CI 4.2–51.6).
Although significant in the developmental model, high
diastolic pressure (> 90mmHg) was not as much of a
risk factor as systolic BP, and thus ceased to have a
significant effect on SMO risk in the validation model
and the performance checking model with the whole
data (Table 3). When interactions were considered, dia-
stolic blood pressure was found to be strongly collinear
(correlation coefficient, r = 0·95) with systolic blood pres-
sure. When applied in the validation data set (n = 900)
and the whole dataset (n = 5243, for sensitivity analysis),
all other variables in the developmental model produced
a consistent effect in the same direction with variations
in effect sizes (Table 3). Similarly, the clinical variables
with the highest risk of SMO in the two models were
fever and tachypnoea, with odds ratios of 123.2 (95% CI,
62.8–137.0) and 18.2 (95% CI, 3.4–24.3) in the validation
model, and 55.9 (95% CI, 22.6–138.0) and 23.2 (95% CI,
9.2–58.6) in the performance checking model with the
whole data (Table 3).
Predictive accuracy for SMO
The developmental model explained 66% of the variabil-
ity in SMO with AUROC of 92% (Table 4, Additional
file 3). Given that the cases data set provides already
categorised (binary) clinical variables, the diagnostic ac-
curacy of the models was assessed based on the number
of parameters required to predict SMO with the best
screening properties. Using the presence of five or more
triggers as the cut-off point to define SMO, the model
predicted SMO with a sensitivity of 86%, a specificity of
92%, positive and negative predictive values of 84 and
93% (Table 4). The validation model produced very simi-
lar screening characteristic and discriminatory ability
(AUROC 92%) (Table 4, Additional file 4). Not surpris-
ingly, however, the sensitivity model with all cases and
Table 1 Characteristics of women with severe maternal
outcome (n = 4243) compared with controls who were
discharged without SMO diagnosis (n = 1000)
Variable SMO cases Controls P-Value
Age at baseline, mean (SD) 27·8 (6·5) 26·8 (6·1) < 0·001
Weight on admission, mean (SD) 75·7 (14·9) 67·2 (13·9) 0·002
Height in meters, mean (SD) 1·6 (0·1) 1·6 (0·3) < 0·001
Days on admission, mean (SD) 6·8 (5·2) 1·6 (0·7) 0·040
Number of ANC Visits, mean (SD) 4·6 (3·5) 3·6 (2·9) < 0·001
Last PCV, mean (SD) 27·6 (9·8) 33·3 (5·9) < 0·001
Parity, mean (SD) 4·5 (2·0) 4·4 (1·0) > 0·050
Gestational age in weeks, mean (SD) 35·8 (4·5) 38·4 (4·7) < 0·001
Table 2 Statistically significant clinical variables from univariate analysis (dependent variable; SMO binary outcome variable) in the
model design dataset (n = 600)
Parameters Cases N = 200 Controls N = 400 Chi-square significance
High systolic blood pressure (> 140), number (%) 75 (68·8) 34 (31·2) < 0·001
Low systolic blood pressure (< 90), number (%) 58 (61·7) 36 (38·3) < 0·001
High diastolic blood pressure (> 90), number (%) 75 (64·7) 41 (35·3) < 0·001
Low diastolic blood pressure (< 60), number (%) 110 (65·5) 58 (34·5) < 0·001
Severe tachypnoea (RR > 40), number (%) 26 (92·9) 2 (7·1) < 0·001
Severe bradypnea (RR < 6), number (%) 5 (100) 0 (0) < 0·001
Fever (Temp> 38), number (%) 17 (94·4) 1 (5·6) < 0·001
Marked tachycardia (PR > 120), number (%) 58 (71·6) 23 (28·4) < 0·001
Hypoxaemia (SP02 < 90%), number (%) 14 (82·4) 3 (17·6) < 0·001
Caesarean delivery in present admission, number (%) 51 (94.4) 3 (5·6) 0·001
Low urinary output (300 ml/24 h), number (%) 12 (100) 0 (0) < 0·001
Prolonged unconsciousness (GCS < 8/15), number (%) 14 (100) 0 (0) < 0·001
Blood transfusion in present admission, number (%) 40 (67·8) 19 (32·8) 0·038
Last haematocrit level, mean (SD) 27·6 (9·8) 33·3 (5·9) < 0·001
Days of admission, mean (SD) 6·8 (5·2) 1·6 (0·7) 0·040
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controls produced the highest positive predictive value (94%),
but a significantly reduced negative predictive value (61%).
This is expected given the high prevalence of the outcome
measure in the data set (case: control = 4:1). The model ex-
plained 58% of the variability in SMO with 92% discriminatory
ability (AUROC 82%) (Table 4, Additional file 5).
Proposed EWS algorithm
Measurements of temperature, pulse rate, systolic blood
pressure, respiratory rate and mode of birth in postpar-
tum women (caesarean birth versus vaginal birth), con-
stitute the primary early warning parameters from the
three statistical models. Diastolic blood pressure was
dropped as it was strongly collinear with systolic blood
pressure (r = 0·95), and the latter was more clinically
relevant and significant in all statistical models (Table
3). Consciousness level and low urinary output (anuria)
were dropped in the statistical models due to the perfect
prediction of outcome, not statistical significance; this
implied that none of the controls (n = 1000) suffered
prolong unconsciousness (GCS < 8/15) or experienced
low urinary output. Although the two variables were
strongly significant predictors of SMO at univariate level
(Table 2), they were dropped in the statistical models.
Therefore, both variables were forced into the proposed
obstetric EWS algorithm, adopting the AVPU (alert, re-
sponds to voice or pain and unresponsive) for conscious-
ness level from the MEOWS chart recommended in the
2003–2005 CEMACH report (Additional files 1 and 2).
Defining trigger as a single markedly abnormal observa-
tion (red trigger) or the combination of two simultan-
eously mildly abnormal observations (two yellow
triggers), the corresponding values from the CEMACH
MEOWS chart (Additional file 1) were converted into
scores of 0 (normal observation), 1 (yellow trigger) and 2
(red trigger) in the proposed algorithm (Table 5). Mode
of birth was scored as 0 and 1 for vaginal and caesarean
births.
Discussion
This study, to our knowledge, reports for the first time
the development and validation of an obstetric diagnos-
tic prediction model for a general obstetric population
in a low resource setting using recommended method-
ology [10]. The final developmental model comprised
abnormal systolic blood pressure (SBP > 140mmHg or <
90mmHg), high diastolic blood pressure (> 90 mmHg),
respiratory rate (RR > 40/min), temperature (> 38oC),
pulse rate (PR > 120/min), caesarean birth, and the num-
ber of previous caesarean births. The model was 86%
(95% CI 81–90) sensitive and 92% (95% CI 89–94)
Table 3 Odds ratios for SMO of the significant predictor
variables
Parameters Odds
ratio*
S. E Significance
(p)
95% CI
Lower Upper
Developmental model (n = 600; 200 cases versus 400 controls)
sBP > 140mmHg 5·26 0·49 0·001 2·03 13·63
sBP < 90mmHg 3·73 0·42 0·002 1·65 8·41
dBP > 90mmHg 2·78 0·48 0·035 1·08 7·16
RR > 40 cycles/min. 25·20 0·92 < 0·001 4·19 51·60
Temp> 38 °C 116·51 1·12 < 0·001 12·96 147·42
PR > 120/min 4·62 0·43 < 0·001 2·00 10·66
CS (Yes vs No) 5·91 0·38 < 0·001 2·79 12·53
Number of CS 0·96 0·01 < 0·001 0·95 0·97
Validation model (n = 900); 300 cases versus 600 controls)
sBP > 140mmHg 8.61 0·56 < 0·001 4·32 32·82
sBP < 90mmHg 5.·42 0·33 0·002 2·66 7·35
dBP > 90mmHg 2·80 0·45 0·119 0·65 8·70
Temp> 38 °C 123·21 2·95 0·002 62·83 136·95
RR > 40 cycles/min 18·21 2·40 < 0·001 3·43 24·31
CS (yes vs. no) 5·85 1·42 < 0·001 3·59 11·19
Number of CS 0·97 0·06 < 0·001 0·95 0·99
PR > 120/min 4·84 0·40 < 0·001 1·69 9·08
Performance checking model with total data set (n = 5243)
sBP > 140mmHg 15·50 0·31 < 0·001 8·38 28·69
sBP < 90mmHg 2·09 0·20 < 0·001 1·42 3·08
dBP > 90mmHg 0·89 0·30 0·706 0·50 1·61
RR > 40 cycles/min 23·19 0·47 < 0·001 9·18 58·57
Temp > 38 °C 55·90 0·46 < 0·001 22·64 138·02
CS (yes vs no) 6·38 0·16 < 0·001 4·71 8·65
Number of CS 0·98 0·00 < 0·001 0·98 0·98
PR > 120 6·27 0·21 < 0·001 4·14 9·50
*Absolute risk estimated by rounding the odds ratios to one significant figure
Table 4 Predictive accuracy of the SMO models (best performing cut-off 0.6)
Model Sensitivity (%) (95%,
CI)
Specificity (%) (95%,
CI)
PPV (%) (95%,
CI)
NPV (%) (95%,
CI)
AUROC (95%,
CI)
Negelkerke
R2
Developmental model
(n = 600)
86 (81–90) 92 (89–94) 84 (79–89) 93 (90–95) 0·92 (0·90–0·95) 0·69
Validation model (n = 900) 81 (76–86) 90 (87–93) 81 (75–85) 90 (87–93) 0·92 (0·88–0·94) 0·69
Sensitivity model
with whole data (n = 5243)
91 (90–92) 71 (68–74) 94 (93–95) 61 (58–64) 0·92 (0·90–0·95) 0·58
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specific in predicting SMO with AUROC of 92% (95%
CI 90–95%). We proposed a score-based obstetric EWS
algorithm with seven clinical parameters (RR,
temperature, systolic BP, pulse rate, consciousness level,
urinary output and mode of birth) that has a potential
for clinical use in low-resource settings.
A previous study in the United Kingdom using a simi-
lar methodology produced an obstetric EWS with similar
discriminatory properties (AUROC) 96% (95% CI 92–
99%) [18]. Although that study by Carle et al. (2013) had
a larger sample size (model development n = 2240) and
validation n = 2200), the dataset used was for women ad-
mitted to ICU and the EWS included the fraction of in-
spired oxygen and arterial blood gas, these may limit its
use in a low resource setting [19, 25, 26], We did not
have the fraction of inspired oxygen in our dataset but
found that low SPO2 was not a significant predictor of
SMO risk in our final model. It would have been useful
to assess that performance on our dataset, but this was
impossible because the clinical variables in the SMO
cases of our dataset were collected as categorical (binary)
variables.
We found that temperature > 38o C was a predictor of
SMO, similar to findings of Ryan et al. (2015) [27] and
Singh et al. (2012) [15]. Our finding of high systolic BP
as a predictor of SMO was consistent with findings of
two inpatient obstetric ward-based validation studies
which used obstetric morbidity [15], as defined by con-
sensus of experts, and ICU admission as outcomes [26],
and an EWS external validation study that had death as
outcome [19]. These findings differed from the develop-
ment and validation study by Carle and colleagues
(2013), that used data within 24 h of admission into
ICU, while the other studies used data from inpatients
that had no obvious need for critical care [18, 28].
Our report of a significant association between SMO
and tachypnoea, high pulse rate, diastolic blood pressure,
and low consciousness level was consistent with the
findings from the ICU-based external validation study by
Paternina-Caicedo et al. [19]
We found a significantly increased risk of SMO among
women who had caesarean compared to vaginal birth,
and this remained an important predictor of SMO in all
our models during development. This informed our in-
clusion of mode of birth in the proposed EWS tool
(Table 5 and Additional file 2).
Our models have excellent predictive ability to dis-
criminate women who developed SMO from those who
did not (AUCs consistently above 90%). The model
attained similar diagnostic predictive accuracy as one de-
veloped, internally [18] and externally [19] validated
using data from obstetric ICU patients in the USA. Our
model also performed similarly to non-obstetric cardio-
vascular, adult critical care and neonatal critical care
score systems [27, 29, 30]. Our models have significantly
better screening characteristics (PPV 94% CI 93–95) as
compared to an average of 41% reported for 16 different
EWS versions [7]. This is of particular significance, since
an EWS that generates many false-positive findings may
worsen clinical care, constituting a nuisance alarm by
creating an excessive burden on health systems [31, 32].
Potentially, the proposed obstetric EWS algorithm pre-
sents an opportunity to institute life-saving interventions
to improve clinical outcome. However, current evidence
suggests that the use of EWS by itself is not enough
to improve health outcomes and that for this tool to
perform optimally, an EWS must be integrated with
an outreach support system, such as a rapid response
team [7, 33].
Of the seven parameters in the proposed EWS algo-
rithm (Table 5 and Additional file 2), five (temperature,
pulse rate, systolic blood pressure, respiratory rate and
consciousness level) were included in the majority (>
80%) of EWSs published to date [7]. Delays in triage
(identification of who is, or may become, severely ill and
should be provided with a higher level of care) are be-
lieved to contribute immensely to an increased burden
of adverse obstetric outcomes in this settings [5]. This is
further confounded by the unavailability of patient mon-
itoring devices and other diagnostic equipment, espe-
cially in primary healthcare settings [26]. Therefore, in
addition to inpatient obstetric wards, we believe the pro-
posed algorithm can present a potentially useful triaging
tool to aid timely referral in primary healthcare centres
Table 5 Scoring guideline for the proposed obstetric EWS algorithm
Parameters 2 1 0 1 2
Temperature < 35 35- < 36 36 - < 38 > 38
Pulse rate < 40 40 - < 50 50 - < 100 100–120 > 120
Respiratory rate 0–10 11–20 21–30 > 30
Systolic blood pressure < 90 90- < 100 100 - < 150 150–160 > 160
Urine volume (ml/hour) < 20 20–30 > 30
Mode of birth CS Vaginal birth CS
Consciousness level
(AVPU)
Response to pain/ unresponsive Response to voice Alert Response to voice Response to pain/ unresponsive
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in LMICs. However, prospective external validation is
recommended to assess the effectiveness of this tool in
primary, secondary and tertiary care in other low re-
source settings to substantiate these recommendations.
Main strengths of our analysis lie in the robust mater-
nal deaths and near-misses data set which was prospect-
ively collected primarily for research purposes with very
few missing data (2·7% of participants), and strict adher-
ence to a diagnostic predictive model development
process and reporting as recommended by TRIPOD
[10]. A limitation of EWS validation studies that were
addressed in our analysis is lack of standardisation of
outcome measures; this is especially common with stud-
ies using morbidity as outcome measures, as often, this
was defined based on consensus rather than standar-
dised definitions [7]. There are several limitations to this
study. Firstly, data of SMO consisted of already cate-
gorised clinical variables. Although cut-offs were based
on recommendations for defining specific disease condi-
tions (such as high blood pressure) by policy-making or-
ganisations like WHO, it was not possible to validate
different trigger thresholds for the model parameters.
Secondly, lack of continuous data also made it impos-
sible to externally validate other EWS versions like
CEMACH’s MEOWS and the ICU based chart devel-
oped by Carle et al. (2013) [18]. Additionally, pulse ox-
imetry was poorly recorded in our study data set,
especially in controls where the parameter was assumed
to be above 90%. Although the absence of oxygen satur-
ation could make our proposed chart more feasible to
use in low resource settings, evidence from other ana-
lyses has shown that it is a valuable predictor of death
and serious obstetric complications [34–37]. This clin-
ical variable would therefore probably still contribute to
a statistically developed and validated EWS decision tool
in our study population. This can be investigated in an
appropriately designed study in the future. Finally, the
performance of our model might have been overesti-
mated by the case-control study design with a high pro-
portion of SMO cases. External validation should
preferably be performed in a cohort study with a repre-
sentative incidence of SMO (2.7% as in the Nigerian
near-miss study).
Conclusion
To the best of our knowledge, this study provides for
the first time an internally validated statistically devel-
oped predictive model for SMO among all women ad-
mitted to obstetric wards in a low resource setting. This
model was used to develop a simple score-based EWS
algorithm that has easy to measure parameters with
readily available patient monitoring tools, hence consti-
tuting a potentially useful triaging tool in low resource
healthcare settings. Further work is, however, needed to
validate this proposed chart externally in obstetric wards
as well as primary healthcare settings.
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